论文部分内容阅读
目的：评价选择性支气管动脉灌注化疗问AI）和胸腔内灌注化疗（Pll）联合治疗晚期非小细胞肺癌（NSCDe）伴恶性胸腔积液（MPE）的疗效。材料和方法：30例病变局限于胸部的晚期NSCLC伴MPE患者。先经BAI治疗2－7天再行PLI。结果：肺部原发灶有效率86．7％，MPE有效率93．3％，6个月、1年、2年生存率分别为对．3％、63．3％、30％。结论：BAI和PLI联合治疗晚期NSCLC伴MPE安全有效，先用BAI，后用PLI，效果较好。
OBJECTIVE: To evaluate the efficacy of selective bronchial arterial infusion chemotherapy (AI) and intrapleural infusion chemotherapy (Pll) in the treatment of advanced non-small cell lung cancer (NSCDe) with malignant pleural effusion (MPE). Materials and Methods: Thirty patients with advanced NSCLC with MPE were confined to the chest. The PLI was first treated with BAI for 2-7 days. Results: The efficiency of primary foci of lung was 86.7%, and the effective rate of MPE was 93.3%. The survival rates of 6 months, 1 year, and 2 years were respectively correct. 3%, 63.3%, 30%. Conclusion: The combination of BAI and PLI is safe and effective in the treatment of advanced NSCLC with MPE. The first use of BAI followed by PLI has a good effect.